Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis

Sue J Sohn1, Gavin M Lewis, Astar Winoto

  • 1Division of Immunology and Cancer Research Laboratory, Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3200, USA.

The EMBO Journal
|June 13, 2008
PubMed

Insights

The MEK5-ERK5 pathway regulates thymocyte apoptosis during T-cell development, distinct from ERK1/2 signaling. This finding clarifies the complex role of mitogen-activated protein kinases in T-cell differentiation and survival.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Mitogen-activated protein kinases (MAPKs) like ERK1/2, p38, and JNK are traditionally linked to thymocyte survival and death decisions.
  • Previous studies using MEK1-ERK1/2 inhibitors yielded ambiguous results, potentially due to off-target effects on other MAPK pathways.
  • The role of the MEK5-ERK5 pathway, a homolog of ERK1/2, in T-cell development remained unclear.

Purpose of the Study:

  • To elucidate the specific contribution of the MEK5-ERK5 signaling pathway in T-cell development.
  • To differentiate the functions of the MEK5-ERK5 pathway from the well-studied ERK1/2 pathway in thymocytes.

Main Methods:

  • Retroviral expression of dominant-negative and constitutively activated MEK5 constructs in developing thymocytes.
  • Analysis of thymocyte apoptosis and positive selection.
  • Assessment of downstream effector pathways, including Nur77 family members and Bim.

Main Results:

  • MEK5 activity was found to regulate thymocyte apoptosis.
  • The MEK5-ERK5 pathway did not play a significant role in positive selection.
  • ERK5 activity correlated with Nur77 family member levels, but not Bim levels, in thymocytes.

Conclusions:

  • The MEK5-ERK5 pathway plays a critical, distinct role in regulating thymocyte apoptosis during T-cell development.
  • These findings highlight the intricate MAPK network's involvement in mediating differential outcomes in T-cell differentiation and apoptosis.
  • The study underscores the need to consider specific MAPK pathways when investigating T-cell fate determination.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.